Celldex Therapeutics buy Citigroup Inc.
Start price
07.10.24
/
50%
€28.20
Target price
07.10.25
€63.74
Performance (%)
-20.57%
End price
08.10.25
€22.40
Summary
This prediction ended on 08.10.25 with a price of €22.40. The price of Celldex Therapeutics has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.57%. Citigroup_Inc_ has a follow-up prediction for Celldex Therapeutics where he still thinks Celldex Therapeutics is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Celldex Therapeutics | 8.393% | 8.393% | 84.211% |
| iShares Core DAX® | 2.573% | 3.502% | 8.408% |
| iShares Nasdaq 100 | 4.858% | 0.654% | 28.383% |
| iShares Nikkei 225® | 5.590% | -0.246% | 52.915% |
| iShares S&P 500 | 3.250% | 2.083% | 24.370% |
Comments by Citigroup_Inc_ for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $70.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
In the thread Trading Celldex Therapeutics
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.08.25
20.08.25
€41.27
20.08.26
20.08.26
96.20%
06.08.26
06.08.26
